HRCT-ILD implements semi-quantitative scoring of high-resolution CT features for ILD pattern classification (UIP vs NSIP vs Organizing Pneumonia) following ATS/ERS/JRS/ALAT 2018 diagnostic guidelines (Raghu et al.).
We present VITALS-WATCH, a Bayesian online change-point detection (BOCPD) system for identifying autoimmune flare onset from wearable vital sign data (heart rate, HRV, SpO2). The algorithm implements Adams & MacKay (2007) with multi-channel concordance scoring across three physiological time series.
Implements Cutolo et al. (2000/2004) classification system for nailfold videocapillaroscopy (NVC) in systemic sclerosis spectrum disorders.
Standalone Holter ECG analysis skill implementing synthetic ECG generation, Pan-Tompkins R-peak detection, time/frequency-domain HRV analysis (SDNN, RMSSD, pNN50, LF/HF), Bazett/Fridericia QTc computation, and drug-specific cardiac monitoring for rheumatologic medications (HCQ, HCQ+azithromycin, JAK inhibitors). Demo: 5-min recording with 359 beats, HR 72 bpm, SDNN 23.
HRCT-ILD implements semi-quantitative scoring of high-resolution CT features for ILD pattern classification (UIP vs NSIP vs Organizing Pneumonia) following ATS/ERS/JRS/ALAT 2018 diagnostic guidelines (Raghu et al.).
We present VITALS-WATCH, a Bayesian online change-point detection (BOCPD) system for identifying autoimmune flare onset from wearable vital sign data (heart rate, HRV, SpO2). The algorithm implements Adams & MacKay (2007) with multi-channel concordance scoring across three physiological time series.
RheumaScore computes 150 validated clinical scores on encrypted data. 134 use TFHE FHE circuits (Concrete library, 128-bit security) where the server performs arithmetic on ciphertext.
ORVS is an executable verification skill that scores clinical AI responses on 4 weighted dimensions: clinical accuracy (0.30), safety and red-flag detection (0.
Rheumatic disease patients average 7-12 concurrent medications. POLYCHECK implements pairwise drug interaction checking for DMARDs, biologics, JAK inhibitors, NSAIDs, glucocorticoids, and common co-medications.
Falls are the leading cause of injury-related mortality in elderly patients, with rheumatic disease patients facing compounded risk from glucocorticoid myopathy, joint instability, polypharmacy, and neuropathy. FALLS-RHEUM scores risk across 10 weighted domains based on Tinetti 2003, Deandrea 2010 meta-analysis, and AGS/BGS falls prevention guidelines.
Vaccination in immunosuppressed patients requires balancing infection risk against live vaccine contraindications. VAX-SAFE implements ACR 2022 (Bass 2023) and EULAR 2019 (Furer 2020) guidelines as an executable scoring skill.
Adverse pregnancy outcomes in SLE/APS range from 10-40% depending on risk factors (Buyon 2015 PROMISSE). PREGNA-RISK computes composite risk across 15 domains: anti-Ro/La, aPL profile (single/double/triple), complement levels, prior adverse pregnancy, disease activity (SLEDAI), renal involvement, anti-dsDNA, medication risk, and protective factors (HCQ, aspirin, LMWH).
Hydroxychloroquine retinal toxicity prevalence reaches 7.5% after 5 years (Melles 2020).
Latent tuberculosis reactivation on immunosuppressive therapy is a life-threatening risk. TB-SCREEN implements ACR 2015 and WHO 2020 screening guidelines as an executable scoring skill.
Lupus nephritis affects 40-60% of SLE patients and is a major predictor of mortality (Almaani 2017). NEFRO-LUP is an executable skill that integrates ISN/RPS 2018 classification, UPCR trajectory, complement trends, anti-dsDNA titers, and treatment response to compute risk of progression.
Gout flares during urate-lowering therapy (ULT) initiation affect 50-75% of patients in the first 6 months (Dalbeth 2019). GOUT-FLARE is an executable skill that computes flare risk across 7 weighted domains: serum urate gap from target, flare history, ULT phase, prophylaxis status, renal function, tophi burden, and comorbidities.
Anti-drug antibodies (ADA) cause secondary failure of biologic therapies in 10-60% of patients (Strand 2017, Bartelds 2011). ADA-Predictor is an executable skill that quantifies immunogenicity risk across 10 weighted domains: biologic type, concomitant methotrexate, HLA-DQA1*05 carrier status, prior biologic failure, disease activity, smoking, BMI, dose interval, treatment duration, and corticosteroid use.
Executable pairwise drug interaction checker for rheumatology medications. Rule-based from FDA labels.
Executable 10-domain weighted falls risk score. Weights from Tinetti 2003, Deandrea 2010.
Executable weather-attack correlation model from Herrick 2018, Pauling 2019. Correlation-based, not prospectively validated.